Literature DB >> 21459020

Review of metastasizing (malignant) ameloblastoma (METAM): pattern of metastasis and treatment.

Ramya Kumari Gamagedera Dissanayake1, Primali Rukmal Jayasooriya, Dedduwa Jayatunge Leel Siriwardena, Wanninayake Mudiyanselage Tilakaratne.   

Abstract

OBJECTIVES: The rare malignant odontogenic tumor, metastasizing (malignant) ameloblastoma (METAM) is reviewed with the aim of analyzing the pattern of disease and treatment of cervical metastasis based, on 2005 World Health Organization classification. STUDY
DESIGN: A total of 65 cases, including reported cases from 1923 to 2009 compatible with the current classification and a new case are reviewed.
RESULTS: METAM occurred mostly in lungs (71%), followed by cervical lymph nodes (28%). Female-to-male ratio was 1:1.1. Primary tumor was diagnosed in 28% of cases at ages ≤ 20 years, and maxilla-to-mandible ratio was 1:5.2. The mean disease-free interval and survival for pulmonary metastasis were 14.37 years and 3 years, respectively, and 12.96 years and 6 years for cervical METAM. Five-year survival rate for cervical metastasis treated purely surgically was 71.43%.
CONCLUSIONS: According to the available literature, neck dissection is the treatment of choice for cervical METAM. Evidence for the role of chemotherapy and radiotherapy is not conclusive.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21459020     DOI: 10.1016/j.tripleo.2010.12.018

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  14 in total

1.  Rare case of ameloblastoma with pulmonary metastases.

Authors:  Ivan Valkadinov; Nikolay Conev; Dian Dzhenkov; Ivan Donev
Journal:  Intractable Rare Dis Res       Date:  2017-08

2.  Overwhelming hypercalcaemia in mandibular ameloblastoma.

Authors:  Tom Edward Ngo Lo; Cesar Vincent Villafuerte; Laura Trajano Acampado
Journal:  BMJ Case Rep       Date:  2014-10-17

Review 3.  Ameloblastoma and Intracranial Involvement: The Current Challenge of the Radical Surgical Treatment. Comprehensive Review of the Literature and Institution experience.

Authors:  Daniele Armocida; Luigi Valentino Berra; Resi Pucci; Andrea Battisti; Marco Della Monaca; Valentino Valentini; Antonio Santoro
Journal:  J Maxillofac Oral Surg       Date:  2021-09-24

4.  Metastatic pulmonary ameloblastoma misdiagnosed as primary squamous cell carcinoma preoperatively.

Authors:  Ju Sik Yun; Do Wan Kim; Sung Sun Kim; Yoo Duk Choi; Sang Yun Song; Kook Joo Na
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2014-02-05

5.  A repeatedly recurrent desmoplastic ameloblastoma after removal and allobone graft: Radiographic features compared with histological changes.

Authors:  Jae-Duk Kim; Hyun-Seon Jang; Yo-Seob Seo; Jin-Soo Kim
Journal:  Imaging Sci Dent       Date:  2013-09-23

6.  Current concepts and occurrence of epithelial odontogenic tumors: I. Ameloblastoma and adenomatoid odontogenic tumor.

Authors:  Suk Keun Lee; Yeon Sook Kim
Journal:  Korean J Pathol       Date:  2013-06-25

7.  Malignant ameloblastoma (metastatic ameloblastoma) in the lung: 3 cases of misdiagnosis as primary lung tumor with a unique growth pattern.

Authors:  Rui Bi; Lei Shen; Xiongzeng Zhu; Xiaoli Xu
Journal:  Diagn Pathol       Date:  2015-07-25       Impact factor: 2.644

8.  Metastasizing Ameloblastoma: A 10 Year Clinicopathological Review with an Insight Into Pathogenesis.

Authors:  Deepak Pandiar; Rahul Anand; Mala Kamboj; Anjali Narwal; P M Shameena; Anju Devi
Journal:  Head Neck Pathol       Date:  2021-01-04

9.  A case of recurrent metastatic ameloblastoma and hypercalcaemia successfully treated with carboplatin and paclitaxel: long survival and prolonged stable disease.

Authors:  Af Ghiam; A Al Zahrani; R Feld
Journal:  Ecancermedicalscience       Date:  2013-06-04

10.  Unicystic ameloblastoma metastasizing to multiple cervical lymph nodes.

Authors:  Kazuma Noguchi; Hiromitsu Kishimoto; Koji Yamanegi; Kuniyasu Moridera; Kazuki Takaoka; Masahiro Urade
Journal:  J Surg Case Rep       Date:  2013-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.